events
05 July 2022
Jean De Gunzburg speaker at the 8th Annual Microbiome Connect Europe 2022 on July 6 at 11.30am CET
Jean De Gunzburg will attend the 8th Annual Microbiome Connect: Europe 2022 on July 6-7 2022 and participate as a…
The US Patent and Trademark Office has recently granted a new patent for Da Volterra in the USA. The patent received number 9,968,562 and includes claims covering composition of matter and methods of use for DAV132, our innovative product designed to protect the intestinal microbiota in patients taking antibiotics.
This patent reinforces our intellectual property portfolio and comes as a complement to the already 100+ patents protecting DAV132 worldwide.